Dr Reddys Laboratories announces the relaunch of Zenatane in the US Market Kumar Jeetendra | June 3, 2019 Hyderabad, India and Princeton, NJ, USA. June 3, 2019 — Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the re-launch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg a therapeutic equivalent generic version of Accutane®, …
Indias Biggest Pharma Expo in the National Capital Kumar Jeetendra | June 15, 2019 Indian Pharma Expo 2019 is coming up on 16th, 17th & 18th July at Hall 12A Pragati Maidan, New Delhi. New Delhi: India’s famous Pharma event “Indian Pharma Expo 2019” will be inaugurated on 16th July at HALL No. 12A, Pragati Maidan, New Delhi. At the time of inauguration Key dignitaries from Department of Pharmaceuticals, …
DuPont Nutrition and Biosciences Introduces HOWARU PROTECT PRENATAL Kumar Jeetendra | June 21, 2019 Delivering Clinically Documented Immune, Mood and Vaginal Benefits for Women During Pregnancy.rn WILMINGTON, Del., June 20, 2019 – DuPont Nutrition & Biosciences has announced the launch of HOWARU® Protect Prenatal+, an innovative probiotic formula that has been clinically proven to deliver mood, vaginal and immune health benefits for women during pregnancy and beyond. DuPont Nutrition …
Sun Pharma and China Medical System Holdings enter into a License Agreement for Cyclosporine A eye drops in Greater China Kumar Jeetendra | June 28, 2019 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO,Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that one of its wholly owned subsidiaries has entered into an exclusive licensing agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for the development and commercialization of Cyclosporine A …
Sun Pharma and China Medical System Holdings enter into a License Agreement for Cyclosporine A eye drops in Greater China Kumar Jeetendra | June 28, 2019 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO,Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that one of its wholly owned subsidiaries has entered into an exclusive licensing agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for the development and commercialization of Cyclosporine A …
Sun Pharma and China Medical System Holdings enter into a License Agreement for Cyclosporine A eye drops in Greater China Kumar Jeetendra | June 28, 2019 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO,Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that one of its wholly owned subsidiaries has entered into an exclusive licensing agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for the development and commercialization of Cyclosporine A …
